Assistant Professor of Medicine
Professor of Medicine
Principle Investigator: Raj Vuppalanchi, MD
Duration: 21 weeks
Patient Population: Patients with moderate to severe itching.
Drug(s): Oral CR845
Interested in this study? Please contact the coordinator below:
Duration: 26 weeks
Patient Population: Non-cirrhotic
Drug(s): Oral Saroglitazar
Duration: Upwards 6 - 8 years.
Patient Population: PBC with total Bili > ULN and ≤3x ULN or ALP >5x ULN
Drug(s): Obeticholic Acid tablet or placebo
Principle Investigator: Craig Lammert, MD
Duration: 1 visit
Patient Population: PBC/Pre-Transplant and history of no/minimal itch or severe itch.